Ads
related to: stanford oncology clinical trials training
Search results
Results from the WOW.Com Content Network
He is an oncologist and cancer pharmacologist, and has served as a faculty member at Stanford University since 1979. His research spans basic, translational, and clinical research and investigates the mechanisms of drug resistance and the development of new anticancer therapies.
The trial was conducted at the Stanford Center for Cancer Cell Therapy, which modified the chimeric antigen receptor T cell (CAR-T) to identify B-cell prolymphocytic leukemia and B-cell lymphoma. [ 34 ] [ 35 ] In 2022, Mackall was awarded $11.9 million from the California Institute of Regenerative Medicine to lead a clinical trial using T cells ...
The Stanford Cancer Institute was founded in 2004 and first received NCI-designation as a clinical cancer center in 2007. In 2016, it received its comprehensive cancer center designation. [3] [1] In 2022, the Stanford Cancer Institute received its comprehensive cancer center designation renewal.
The Medical Scientist Training Programs (MSTPs) are dual-degree training programs that streamline the education towards both clinical (typically MD) and research doctoral degrees. [1] MSTPs are offered by some United States medical schools, who are awarded financial support from the National Institute of General Medical Sciences , a branch of ...
Comprehensive cancer centers may apply for up to $1.5 million per year from the Department of Health and Human Services. [2] Clinical Cancer Centers generally conduct a combination of basic, population sciences, and clinical research, and are encouraged to stimulate collaborative research involving more than one field of study. Clinical cancer ...
Lee completed a radiation oncology residency at the University of California, San Francisco in 1997. [2] In 1997, Le joined the Stanford University School of Medicine as a clinical instructor focused on brain and lung cancers. [1] [2] In 2004, she became a co-director of the radiation biology program at the Stanford Cancer Institute. [2]
In 2003, she was given a Merit Award from the American Society of Clinical Oncology. [2] She is the lead investigator on the ECOG-ARIN clinical trials group at Stanford, and was given a Young Investigator Award from ECOG-ARIN in 2015. [4] She serves on the board of directors of the International Association for the Study of Lung Cancer. [5]
She believes that breast cancer tumors have genetic differences that respond differently to treatments. [11] In 2019, she combined molecular analysis and historical clinical data to create the largest breast cancer cohort. In this cohort she found four groups of tumors that occur later in life, up to 20 years after the initial cancer diagnosis.
Ads
related to: stanford oncology clinical trials training